- Potential benefitIncreases public access to HHS-held clinical data on COVID-19 vaccines before child schedule inclusion.
- Potential benefitMay increase parental confidence by allowing independent review of vaccine safety and efficacy data.
- Potential benefitCould improve scientific reproducibility and external analyses by making deidentified datasets publicly available.
Protecting Our Children from the CDC Act
Referred to the House Committee on Energy and Commerce.
The bill prohibits the HHS Secretary and HHS offices from placing any COVID-19 vaccine on the child and adolescent immunization schedule unless the CDC posts all clinical data HHS possesses about that vaccine’s safety and efficacy on the CDC public website. It requires deidentification of posted data, removes any COVID-19 vaccine currently on that schedule upon enactment, and allows re‑inclusion only if the posting requirement and other laws are met.
Liberals emphasize public‑health disruption; conservatives emphasize transparency and parental control.
Relative to its intended legislative type, this bill plainly creates a new statutory condition and immediate substantive effect on vaccine scheduling, but it lacks detailed definitions, procedural rules, funding provisions, and accountability mechanisms that would be expected for a durable policy change of this scope.
The bill prohibits the HHS Secretary and HHS offices from placing any COVID-19 vaccine on the child and adolescent immunization schedule unless the CDC posts all clinical data HHS possesses about that vaccine’s safety and efficacy on the CDC public website.
It requires deidentification of posted data, removes any COVID-19 vaccine currently on that schedule upon enactment, and allows re‑inclusion only if the posting requirement and other laws are met.
The provision applies to the ACIP child and adolescent immunization schedule (or any successor).
Narrow statutory change but politically charged; low fiscal impact helps, yet controversy and lack of compromise features reduce chances of enactment.
Relative to its intended legislative type, this bill plainly creates a new statutory condition and immediate substantive effect on vaccine scheduling, but it lacks detailed definitions, procedural rules, funding provisions, and accountability mechanisms that would be expected for a durable policy change of this scope.
Liberals emphasize public‑health disruption; conservatives emphasize transparency and parental control.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenImmediate removal of existing pediatric COVID vaccines could reduce vaccination uptake and preventive coverage.
- Potential burdenRequiring posting of 'all clinical data' may delay ACIP recommendations and slow access to vaccines.
- Potential burdenPreparing, deidentifying, and posting datasets imposes administrative costs and staff workload on HHS.
Why the argument around this bill splits.
Liberals emphasize public‑health disruption; conservatives emphasize transparency and parental control.
Likely to view the transparency goal as understandable in principle but problematic in practice.
Opposed to automatic removal of COVID vaccines from the schedule because it could reduce vaccination coverage and harm child public health.
Concerned the requirement could politicize CDC processes and delay standard public‑health protections.
Sees value in greater transparency of vaccine data but worries about practicality and unintended consequences.
Concerned removal from the schedule could disrupt school requirements, insurance coverage, and immunization programs.
Would look for clarifications on what constitutes “all clinical data,” timelines, and protections for proprietary or privacy interests.
Likely to favor the bill as a strong transparency and parental‑rights measure.
Views requirement and automatic removal as corrective oversight of federal public‑health agencies.
Appreciates mandatory public posting of safety and efficacy data before children are targeted for vaccination.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow statutory change but politically charged; low fiscal impact helps, yet controversy and lack of compromise features reduce chances of enactment.
- What constitutes 'all clinical data' and scope of third‑party proprietary material
- Practical timeline and cost to compile and deidentify large datasets
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals emphasize public‑health disruption; conservatives emphasize transparency and parental control.
Narrow statutory change but politically charged; low fiscal impact helps, yet controversy and lack of compromise features reduce chances of…
Relative to its intended legislative type, this bill plainly creates a new statutory condition and immediate substantive effect on vaccine scheduling, but it lacks detailed definitions, procedural rules, funding provisi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.